Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 34: 557-560, 1988;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oka, K.
Right arrow Articles by Noguchi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oka, K.
Right arrow Articles by Noguchi, M.

Clinical Chemistry, Vol 34, 557-560, Copyright © 1988 by American Association for Clinical Chemistry

Changes in the concentration of testosterone in serum during the menstrual cycle, as determined by liquid chromatography

K Oka, T Hirano and M Noguchi
Division of Clinical Pharmacology, Tokyo College of Pharmacy, Japan.

We used a newly developed high-performance liquid chromatographic (HPLC) method to determine the concentration of testosterone in serum from women and compared the results with those obtained by conventional radioimmunoassay. We used a conventional silica gel column and organic solvent mixture (ethanol plus n-hexane containing a small amount of water). The detection limit for testosterone was as low as 0.2 micrograms/L, sufficient to correctly determine the concentration of the hormone in serum from women. For the calibration curve, we plotted the peak-height ratio of testosterone to 19-nortestosterone. The menstrual-cycle-related rhythm of the concentration of testosterone in serum was related to follicular and luteal phase-shifting, the concentration being considerably greater in the luteal phase than in the follicular phase. In contrast, RIA showed only minor and irregular fluctuation in the concentrations of the hormone throughout the menstrual cycle. When we used the HPLC to measure the hormonal change in a woman with an irregular menstrual cycle, we found that her testosterone concentration increased abnormally early after menstruation.


The following articles in journals at HighWire Press have cited this article:


Home page
 J. Clin. Endocrinol. Metab.Home page
E. Diamanti-Kandarakis, C. R. Kouli, A. T. Bergiele, F. A. Filandra, T. C. Tsianateli, G. G. Spina, E. D. Zapanti, and M. I. Bartzis
A Survey of the Polycystic Ovary Syndrome in the Greek Island of Lesbos: Hormonal and Metabolic Profile
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4006 - 4011.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. S. Knochenhauer, T. J. Key, M. Kahsar-Miller, W. Waggoner, L. R. Boots, and R. Azziz
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3078 - 3082.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Association for Clinical Chemistry.